World's Best Scientists 2026 revealed!
Richard M. Bergenstal

Richard M. Bergenstal

D-Index & Metrics

Medicine

D-Index
101
Citations
60575
World Ranking
7802
National Ranking
4068

Richard M. Bergenstal publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard M. Bergenstal sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 470 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard M. Bergenstal D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard M. Bergenstal sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard M. Bergenstal is affiliated with HealthPartners in the United States. Their research primarily spans the field of Medicine with a strong focus on Endocrinology, Diabetes, and Metabolism. With a publication record emphasizing diabetes management and treatment, Bergenstal's work contributes to clinical practices and advances in automated insulin delivery and glucose monitoring technologies.

Their research covers several main topics including:

  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diabetes Management and Education
  • Diet and metabolism studies

Frequent co-authors include:

  • Roy W. Beck
  • Anders L. Carlson
  • Tadej Battelino
  • Mary L. Johnson
  • Thomas W. Martens

Bergenstal's publications are found extensively in the following venues:

  • Diabetes
  • Diabetes Technology & Therapeutics
  • Journal of Diabetes Science and Technology
  • Diabetes Care
  • UNC Libraries

Notable recent papers authored or co-authored by Bergenstal include:

  • "Continuous glucose monitoring and metrics for clinical trials: an international consensus statement" (2022) published in The Lancet Diabetes & Endocrinology
  • "Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin" (2021) published in JAMA
  • "Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice" (2022) published in Endocrine Reviews
  • "A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial" (2021) published in The Lancet
  • "Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes" (2021) published in Diabetes Care

In addition to research articles, Bergenstal has contributed to book publications, including a title released by La Trobe University titled "Role of Continuous Glucose Monitoring in Diabetes Treatment" (2020).

Best Publications

  • Diabetes and Cancer: A consensus report

    Edward L. Giovannucci;David M. Harlan;Michael C. Archer;Richard M. Bergenstal

  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E Inzucchi;Richard M Bergenstal;John B Buse;Michaela Diamant

  • Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

    William B. White;Christopher P. Cannon;Simon R. Heller;Steven E. Nissen

  • Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    Tadej Battelino;Thomas Danne;Richard M. Bergenstal;Stephanie A. Amiel

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

    Kellee M. Miller;Nicole C. Foster;Roy W. Beck;Richard M. Bergenstal

  • Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379

    SE Inzucchi;RM Bergenstal;JB Buse;M Diamant

  • The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

    Denise E Bonds;Michael E Miller;Richard M Bergenstal;John B Buse

  • Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

    Richard M. Bergenstal;William V. Tamborlane;Andrew Ahmann;John B. Buse

  • Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

    Roy W Beck;Tonya Riddlesworth;Katrina Ruedy;Andrew Ahmann

  • Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial

    Melanie J. Davies;Richard Bergenstal;Bruce Bode;Robert F. Kushner

  • Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

    Richard M Bergenstal;Carol Wysham;Leigh MacConell;Jaret Malloy

  • Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Threshold-based insulin-pump interruption for reduction of hypoglycemia

    Richard M. Bergenstal;David C. K Klonoff;Satish K. Garg;Bruce W. Bode

  • A new look at screening and diagnosing diabetes mellitus

    Christopher D. Saudek;William H. Herman;David B. Sacks;Richard M. Bergenstal

  • Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.

    Roy W. Beck;Richard M. Bergenstal;Tonya D. Riddlesworth;Craig Kollman

  • Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

    Richard M. Bergenstal;Satish Garg;Stuart A. Weinzimer;Bruce A. Buckingham

  • Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.

    John B Buse;Richard M Bergenstal;Leonard C Glass;Cory R Heilmann

  • Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

    Satish K Garg;Stuart A Weinzimer;William V Tamborlane;Bruce A Buckingham

  • Erratum: Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia (2013) 56 (680))

    S. E. Inzucchi;R. M. Bergenstal;John B Buse;M. Diamant

Frequent Co-Authors

Roy W. Beck
Roy W. Beck University of South Florida
Anne L. Peters
Anne L. Peters University of Southern California
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
Geremia B. Bolli
Geremia B. Bolli University of Perugia
Simon Heller
Simon Heller University of Sheffield
Irl B. Hirsch
Irl B. Hirsch University of Washington
William V. Tamborlane
William V. Tamborlane Yale University
Satish K. Garg
Satish K. Garg University of Colorado Anschutz Medical Campus
David R. Matthews
David R. Matthews University of Oxford
Philip Home
Philip Home Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always follow a single path. There are several online degree options and career pathways for those passionate about healthcare. For registered nurses looking to advance their expertise, an rn to np bridge program allows for a seamless transition to become a nurse practitioner.

If your interests lie in health and wellness, an online nutritionist degree offers a flexible route to entering the field of nutrition and dietetics. For those aiming for leadership or management roles in healthcare, cahme accredited online mha programs are designed to provide quality education in healthcare administration without disrupting your current career.

Additionally, career advancement for nurses has become more accessible with rn to bsn programs that require no clinicals, making it easier than ever to earn a bachelor’s degree online. These options create flexible opportunities to grow your qualifications and expand your career in medicine and beyond.

Best Scientists Citing Richard M. Bergenstal

Trending Scientists

Recently Published Articles